January 22 next meeting of the Transparency Council.
During the session, it was planned:
- Preparation of a position paper on the evaluation of the drug Poteligeo (mogamulizumabum) under drug program B.66. "Treatment of patients with T-cell lymphoma (ICD-10: C84)".
- Preparation of a position paper o...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
